Insulin, Protamine Zinc

CHEMBL2109046 Phase 4 Zugelassen Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A long-acting insulin formulation in which protamine and zinc are added to extend its duration of action, used to provide background blood sugar control in people with diabetes. Its slow absorption from the injection site allows it to work over 24 hours or more.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A long-acting insulin formulation in which protamine and zinc are added to extend its duration of action, used to provide background blood sugar control in people with diabetes. Its slow absorption from the injection site allows it to work over 24 hours or more.

Yes, Insulin, Protamine Zinc is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2109046. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Insulin, Protamine Zinc auf PillFYI

Schnelldaten

Externe Links

ChEMBL CHEMBL2109046

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.